Radioimmunoassay Market was worth USD 395.43 million in 2018

Share on facebook
Share on twitter
Share on linkedin

 

market data forecast | Hyderabad | 12/02/2019:

Recent Developments
DIAsource ImmunoAssays, the universal clinical diagnostics organization part of the BioVendor gathering, declared it had effectively finished synchronous exchanges for the procurement of the full resources of two radioimmunoassay product offerings from its accomplices Svar Life Science and ZenTech, just as the Neolis CgA ELISA item from Svar Life Science.
BioVendor was established in 1992 and is based at the Czech Republic with branches in Germany, the United States, and China. The organization through its subsidiaries develops, manufactures, and distributes medical equipment and research products to scientific institutions in the Czech Republic and universal markets.
To know more, read @ https://www.marketdataforecast.com/market-reports/radioimmunoassay-market-3701/
Market Segmentation
Market Data Forecast published a report named Global Radioimmunoassay Market was worth USD 395.43 million in 2018 and estimated to be growing at a CAGR of 3.52%, to reach USD 470.01 million by 2023.
Report segmented as:
Application:
• Research
• Clinical Diagnostics
End User:
• Hospital
• Pharmaceutical Industry and CRO
• Academics
• Clinical Diagnostic Laboratories
Based on the application, the research segment is expected to dominate the global market. Under the end user, Hospitals are expected to have the largest share in the segment.
Geographical Segmentation:
Based on geography, the global market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. The Radioimmunoassay Market is dominated by North America in 2018 with the region accounting for 36% of the overall market share. North America was followed next in line by Europe and Asia-Pacific. Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region. Another promising region for the market in Latin America, which is expected to show high growth rates in the coming years.
Key Market Players:
• DIAsource ImmunoAssays SA
• Beckman Coulter, Inc.
• IBL International
• PerkinElmer, Inc.
• DRG International, Inc.
• MP Biomedicals, LLC
• Cisbio
• Euro Diagnostica AB
• DiaSorin S.p.A.
• EMD Millipore
• Izotop
• Berthold Technologies GmbH & Co. KG
• Stratec Biomedical AG
View a sample and decide @ https://www.marketdataforecast.com/market-reports/radioimmunoassay-market-3701/request-sample
The Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

 

For more information, please contact
Abhishek Shukla
marketdataforecast
abhishek@marketdataforecast.com
08887098757